We could not find any results for:
Make sure your spelling is correct or try broadening your search.
IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis product... IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Show more
IM Cannabis Reports 2023 Financial Results PR Newswire TORONTO and GLIL YAM, Israel, March 28, 2024 TORONTO and GLIL YAM, Israel, March 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company...
IM Cannabis Reports 2023 Financial Results PR Newswire TORONTO and GLIL YAM, Israel, March 28, 2024 TORONTO and GLIL YAM, Israel, March 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company...
IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization PR Newswire TORONTO and GLIL YAM, Israel, March 25, 2024 By rescheduling medical cannabis, from a...
IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET PR Newswire TORONTO and GLIL YAM, Israel, March 20, 2024 TORONTO and GLIL YAM, Israel...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES...
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company PR Newswire TORONTO and GLIL YAM, Israel, Feb. 28, 2024 Not for distribution to United States...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES...
IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule PR Newswire TORONTO and GLIL YAM, Israel, Jan. 31, 2024 TORONTO and GLIL YAM...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.138 | 44.5161290323 | 0.31 | 0.525 | 0.28 | 2122238 | 0.42635262 | CS |
4 | 0.1257 | 39.0009308098 | 0.3223 | 0.525 | 0.28 | 644939 | 0.41005772 | CS |
12 | 0.098 | 28 | 0.35 | 0.525 | 0.189 | 416542 | 0.36374254 | CS |
26 | -0.1825 | -28.9452815226 | 0.6305 | 0.7217 | 0.189 | 228023 | 0.37091536 | CS |
52 | -0.272 | -37.7777777778 | 0.72 | 1.43 | 0.189 | 146291 | 0.48553542 | CS |
156 | -76.152 | -99.4151436031 | 76.6 | 80.7 | 0.189 | 209117 | 17.12842437 | CS |
260 | -86.052 | -99.4820809249 | 86.5 | 116.3 | 0.189 | 204821 | 17.49963045 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions